The Partnership is governed by a joint Steering Committee of research and administrative leaders from both institutions.
Brooks Jackson, Ph.D.
Dr. Brooks Jackson is dean of the Medical School at the University of Minnesota and vice president for health sciences. Prior to assuming this role in February 2014, Jackson was director of pathology at Johns Hopkins University School of Medicine for 12 years. An internationally recognized researcher in HIV diagnostics, prevention and treatment, Jackson is the principal investigator of the $500 million NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. He is currently Chair of the Blood Products Advisory Committee for the Food and Drug Administration.
Gregory J. Gores, M.D.
Gregory J. Gores, M.D. is a Reuben R. Eisenberg Endowed Professor of Medicine and Physiology. He is also Executive Dean for Research at Mayo Clinic, a Distinguished Investigator of the Mayo Foundation, and a past chair of the Division of Gastroenterology and Hepatology. His clinical and research contributions include advances in our understanding of hepatobiliary malignancies, liver transplantation and mechanisms of liver cell injury. He is the past recipient of a highly prestigious and competitive NIH MERIT Award, currently a Principal Investigator of three NIH R01 grants. He has co-authored more than 500 total publications which have been cited over 25,000 times.
Tucker LeBien, Ph.D.
Dr. Tucker LeBien serves as the Medical School’s vice dean for research, associate vice president for research at the Academic Health Center, and professor in the department of Laboratory Medicine and Pathology at the University of Minnesota. LeBien oversees interdisciplinary research centers, shared resources that provide critical technologies for research faculty, and research compliance and space allocation across the University’s health sciences. As an immunologist, LeBien is a recognized leader in human lymphocyte (blood-cell) development.
Dr. Eric Wieben is the director of Mayo Clinic Genomics Research Center, professor of Biochemistry and Molecular Biology at Mayo Clinic College of Medicine, and the Mayo project leader of the Minnesota Partnership for Biotechnology and Medical Genomics. Dr. Wieben is on the Board of Directors of the BioBusiness Alliance of Minnesota, an industry lead non-profit group that is working to develop biotechnology business ventures. Dr. Wieben’s research efforts are focused in the area of pharmacogenomics: determining how individual genetic differences influence response to drug treatment.